FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nathalie Boyer

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Livers

Physiology

Genotype

Concepts & Ideas

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Christiane Stern; Dominique Valla; Nathalie Boyer; Corinne Castelnau; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Patrick Marcellin
Impact of ribavirin dose on retreatment of chronic hepatitis C patients.
Ana-Carolina Cardoso; Roberto J Carvalho-Filho; Corinne Castelnau; Alexandrine Dipumpo; Nathalie Giuily; Olivier Lada; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Christiane Stern; Dominique-Charles Valla; Tarik Asselah; Pierre Bedossa; Nathalie Boyer; Patrick Marcellin
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
Tarik Asselah; Pierre Bedossa; Ivan Bièche; Maud Blanluet; Nathalie Boyer; Philippe Broët; Simon De Muynck; Ahmed El Ray; Emilie Estrabaud; Olivier Lada; Martine Lapalus; Michèle Martinot-Peignoux; Julien Masliah-Planchon; Marie-Pierre Ripault; Dominique Valla; Dominique Vidaud; Michel Vidaud; Qian Zhang; Patrick Marcellin
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nathalie Boyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Christiane Stern; Dominique Valla; Nathalie Boyer; Corinne Castelnau; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Patrick Marcellin
Impact of ribavirin dose on retreatment of chronic hepatitis C patients.
World journal of gastroenterology : WJG 2012;18(23):2966-72.
2012: Ana-Carolina Cardoso; Roberto J Carvalho-Filho; Corinne Castelnau; Alexandrine Dipumpo; Nathalie Giuily; Olivier Lada; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Christiane Stern; Dominique-Charles Valla; Tarik Asselah; Pierre Bedossa; Nathalie Boyer; Patrick Marcellin
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
Liver international : official journal of the International Association for the Study of the Liver 2012;32(4):612-21.
2012: Tarik Asselah; Pierre Bedossa; Ivan Bièche; Maud Blanluet; Nathalie Boyer; Philippe Broët; Simon De Muynck; Ahmed El Ray; Emilie Estrabaud; Olivier Lada; Martine Lapalus; Michèle Martinot-Peignoux; Julien Masliah-Planchon; Marie-Pierre Ripault; Dominique Valla; Dominique Vidaud; Michel Vidaud; Qian Zhang; Patrick Marcellin
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.
Journal of hepatology 2012;56(3):527-32.
2011: Rami Moucari; Marie-Pierre Ripault; D Valla; M Vidaud; Nathalie Boyer; Corinne Castelnau; M-H N Chanoine; A Dauvergne; V Mackiewicz; P Marcellin
Sequential therapy with adefovir dipivoxil and pegylated interferon alfa-2a for HBeAg-negative patients.
Journal of viral hepatitis 2011;18(8):580-6.
2010: Ana-Carolina Cardoso; Rami Moucari; Claudio Figueiredo-Mendes; Marie-Pierre Ripault; Nathalie Giuily; Corinne Castelnau; Nathalie Boyer; Tarik Asselah; Michèle Martinot-Peignoux; Sarah Maylin; Roberto J Carvalho-Filho; Dominique Valla; Pierre Bedossa; Patrick Marcellin
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.
Journal of hepatology 2010;52(5):652-7.
2010: Michelle Martinot-Peignoux; Christiane Stern; Sarah Maylin; Marie-Pierre Ripault; Nathalie Boyer; Laurence Leclere; Corinne Castelnau; Nathalie Giuily; Ahmed El Ray; Ana-Carolina Cardoso; Rami Moucari; Tarik Asselah; Patrick Marcellin
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
Hepatology (Baltimore, Md.) 2010;51(4):1122-6.
2009: Rami Moucari; Marie-Pierre Ripault; Michèle Martinot-Peignoux; Hélène Voitot; A-C Cardoso; C Stern; Nathalie Boyer; S Maylin; Marie-Hélène Nicolas-Chanoine; Michel Vidaud; Dominique Valla; Pierre Bedossa; Patrick Marcellin
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.
Gut 2009;58(12):1662-9.
2009: Rami Moucari; Anneke Korevaar; Olivier Lada; Michèle Martinot-Peignoux; Nathalie Boyer; Vincent Mackiewicz; Agnes Dauvergne; Ana C Cardoso; Tarik Asselah; Marie-Hélène Nicolas-Chanoine; Michel Vidaud; Dominique Valla; Pierre Bedossa; Patrick Marcellin
High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
Journal of hepatology 2009;50(6):1084-92.
2009: Rami Moucari; Vincent Mackiewicz; Olivier Lada; Marie-Pierre Ripault; Corinne Castelnau; Michèle Martinot-Peignoux; Agnes Dauvergne; Tarik Asselah; Nathalie Boyer; Pierre Bedossa; Dominique Valla; Michel Vidaud; Marie-Hélène Nicolas-Chanoine; Patrick Marcellin
Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.
Hepatology (Baltimore, Md.) 2009;49(4):1151-7.
2009: Sarah Maylin; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Rami Moucari; Ana Carolina Cardoso; Nathalie Boyer; Nathalie Giuily; Corinne Castelnau; M Pouteau; Tarik Asselah; Marie-Hélène Nicolas-Chanoine; Patrick Marcellin
Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody.
Liver international : official journal of the International Association for the Study of the Liver 2009;29(4):511-7.
2009: Rami Moucari; Michèle Martinot-Peignoux; Vincent Mackiewicz; Nathalie Boyer; Marie-Pierre Ripault; Corinne Castelnau; Laurence Leclere; Agnes Dauvergne; Dominique Valla; Michel Vidaud; Marie-Hélène Nicolas-Chanoine; Patrick Marcellin
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2a.
Antiviral therapy 2009;14(8):1183-8.
2009: Michelle Martinot-Peignoux; Sarah Maylin; Rami Moucari; Marie-Pierre Ripault; Nathalie Boyer; Ana-Carolina Cardoso; Nathalie Giuily; Corinne Castelnau; M Pouteau; Christiane Stern; Anne Aupérin; Pierre Bedossa; Tarik Asselah; Patrick Marcellin
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
Antiviral therapy 2009;14(4):501-11.
2008: Sarah Maylin; Michèle Martinot-Peignoux; Rami Moucari; Nathalie Boyer; Marie-Pierre Ripault; Dominique Cazals-Hatem; Nathalie Giuily; Corinne Castelnau; Ana Carolina Cardoso; Tarik Asselah; Cyrille Féray; Marie-Hélène Nicolas-Chanoine; Pierre Bedossa; Patrick Marcellin
Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Gastroenterology 2008;135(3):821-9.
2008: Tarik Asselah; O Lada; Nathalie Boyer; Michèle Martinot; Patrick Marcellin
[Treatment of chronic hepatitis B].
Gastroentérologie clinique et biologique 2008;32(8-9):749-68.
2008: Rami Moucari; Tarik Asselah; Dominique Cazals-Hatem; Hélène Voitot; Nathalie Boyer; Marie-Pierre Ripault; Rodolphe Sobesky; Michèle Martinot-Peignoux; Sarah Maylin; Marie-Hélène Nicolas-Chanoine; Valérie Paradis; Michel Vidaud; Dominique Valla; Pierre Bedossa; Patrick Marcellin
Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Gastroenterology 2008;134(2):416-23.
2007: Tarik Asselah; Olivier Lada; Rami Moucari; Michèle Martinot; Nathalie Boyer; Patrick Marcellin
Interferon therapy for chronic hepatitis B.
Clinics in liver disease 2007;11(4):839-49, viii.
2007: Pierre Bedossa; Rami Moucari; Emna Chelbi; Tarik Asselah; Valérie Paradis; Michel Vidaud; Dominique Cazals-Hatem; Nathalie Boyer; Dominique Valla; Patrick Marcellin
Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study.
Hepatology (Baltimore, Md.) 2007;46(2):380-7.
2007: Rami Moucari; Marie-Pierre Ripault; Valérie Oulès; Michèle Martinot-Peignoux; Tarik Asselah; Nathalie Boyer; Ahmed El Ray; Dominique Cazals-Hatem; Dominique Vidaud; Dominique Valla; Marc Bourlière; Patrick Marcellin
High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy.
Journal of hepatology 2007;46(4):596-604.
2007: Tarik Asselah; Nathalie Boyer; Marie-Pierre Ripault; Michèle Martinot; Patrick Marcellin
Management of chronic hepatitis C.
Minerva gastroenterologica e dietologica 2007;53(1):9-23.
2006: Bach-Nga Pham; Michèle Martinot-Peignoux; Marie-Pierre Ripault; Nathalie Boyer; V Levy; Patrick Marcellin
Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins.
Clinical and experimental immunology 2006;146(2):211-7.
2006: Michèle Martinot-Peignoux; Lorraine Comanor; James Minor; Marie-Pierre Ripault; Bach-Nga Pham; Nathalie Boyer; Corinne Castelnau; Nathalie Giuily; David Hendricks; Patrick Marcellin
Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.
Journal of viral hepatitis 2006;13(10):701-7.
2006: Corinne Castelnau; Frédéric Le Gal; Marie-Pierre Ripault; Emmanuel Gordien; Michèle Martinot-Peignoux; Nathalie Boyer; Bach-Nga Pham; Sarah Maylin; Pierre Bedossa; Paul Dény; Patrick Marcellin; Elyanne Gault
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
Hepatology (Baltimore, Md.) 2006;44(3):728-35.
2006: Valérie Paradis; Tarik Asselah; Delphine Dargere; Marie-Pierre Ripault; Michèle Martinot; Nathalie Boyer; Dominique Valla; Patrick Marcellin; Pierre Bedossa
Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin.
Gastroenterology 2006;130(7):2189-97.
2005: Tarik Asselah; Marie-Pierre Ripault; Corinne Castelnau; Nathalie Giuily; Nathalie Boyer; Patrick Marcellin
The current status of antiviral therapy of chronic hepatitis B.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34 Suppl 1():S115-24.
2005: Frédéric Marrache; Y Consigny; Marie-Pierre Ripault; Dominique Cazals-Hatem; Michèle Martinot; Nathalie Boyer; Claude Degott; Dominique Valla; Patrick Marcellin
Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis.
Journal of viral hepatitis 2005;12(4):421-8.
2005: Patrick Marcellin; Corinne Castelnau; Michèle Martinot-Peignoux; Nathalie Boyer
Natural history of hepatitis B.
Minerva gastroenterologica e dietologica 2005;51(1):63-75.
2004: Tarik Asselah; Corinne Castelnau; Nathalie Boyer; Marie-Pierre Ripault; Patrick Marcellin
[Treatment of chronic hepatitis B].
Gastroentérologie clinique et biologique 2004;28(12):1215-27.
2004: Patrick Marcellin; Tarik Asselah; Marie-Pierre Ripault; Nathalie Boyer
Treatment of chronic hepatitis c.
Minerva gastroenterologica e dietologica 2004;50(1):29-36.
2003: Tarik Asselah; Nathalie Boyer; Marie-Christine Guimont; Dominique Cazals-Hatem; Florence Tubach; K Nahon; H Daïkha; Dominique Vidaud; Michèle Martinot; M Vidaud; Claude Degott; Dominique Valla; Patrick Marcellin
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C.
Gut 2003;52(11):1638-43.
2003: Tarik Asselah; Dominique Vidaud; A Doloy; Nathalie Boyer; Michèle Martinot; M Vidaud; Dominique Valla; Patrick Marcellin
Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy.
Gut 2003;52(6):900-2.
2002: Patrick Marcellin; Corinne Castelnau; Nathalie Boyer
[Treatment of hepatitis B].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2002;23 Suppl 5():535s-536s.
2002: Vincent Di Martino; Thierry Thevenot; Jean-François Colin; Nathalie Boyer; Michèle Martinot; Françoise Degos; Jean-Pierre Coulaud; Jean-Louis Vilde; François Vachon; Claude Degott; Dominique Valla; Patrick Marcellin
Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.
Gastroenterology 2002;123(6):1812-22.
2002: Patrick Marcellin; Nathalie Boyer
[Treatment of patients with chronic hepatitis C who have not been previously treated].
Gastroentérologie clinique et biologique 2002;26 Spec No 2():B194-201.
2002: Michèle Martinot-Peignoux; Nathalie Boyer; Magalie Colombat; Raoudha Akremi; Bach-Nga Pham; Stephan Ollivier; Corinne Castelnau; Dominique Valla; Claude Degott; Patrick Marcellin
Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers.
Journal of hepatology 2002;36(4):543-6.
2002: Vincent Di Martino; Thierry Thevenot; Nathalie Boyer; Dominique Cazals-Hatem; Claude Degott; Dominique Valla; Patrick Marcellin
HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C.
AIDS (London, England) 2002;16(3):441-5.
2002: Manuela G Neuman; Jean-Pierre Benhamou; Marc Bourliere; Asma Ibrahim; Izabella M Malkiewicz; Tarik Asselah; Michèle Martinot-Peignoux; Neil H Shear; Gady G Katz; Raoudha Akremi; Souad Benali; Nathalie Boyer; Laurence Lecomte; Veronique Le Breton; Gaelle Le Guludec; Patrick Marcellin
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Cytokine 2002;17(2):108-17.
2002: Tarik Asselah; Michèle Martinot; Dominique Cazals-Hatem; Nathalie Boyer; A Auperin; Veronique Le Breton; S Erlinger; Claude Degott; Dominique Valla; Patrick Marcellin
Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels.
Journal of viral hepatitis 2002;9(1):29-35.
2001: Vincent Di Martino; P Rufat; Nathalie Boyer; P Renard; Françoise Degos; Michèle Martinot-Peignoux; sophie matheron; V Le Moing; F Vachon; Claude Degott; Dominique Valla; Patrick Marcellin
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Hepatology (Baltimore, Md.) 2001;34(6):1193-9.
2001: Michèle Martinot-Peignoux; Nathalie Boyer; Dominique Cazals-Hatem; Bach-Nga Pham; A Gervais; Veronique Le Breton; S Levy; Claude Degott; Dominique-Charles Valla; Patrick Marcellin
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
Hepatology (Baltimore, Md.) 2001;34(5):1000-5.
2001: A Gervais; Michèle Martinot; Nathalie Boyer; A Auperin; W Le Breton; Claude Degott; Dominique Valla; Patrick Marcellin
Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment.
Journal of hepatology 2001;35(3):399-405.
2001: Manuela G Neuman; Jean-Pierre Benhamou; Izabella M Malkiewicz; Raoudha Akremi; Neil H Shear; Tarik Asselah; Asma Ibrahim; Nathalie Boyer; Michèle Martinot-Peignoux; Pearl Jacobson-Brown; Gady G Katz; Veronique Le Breton; Gaelle Le Guludec; A Suneja; Patrick Marcellin
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.
Clinical biochemistry 2001;34(3):173-82.
2001: A Berson; A Gervais; D Cazals; Nathalie Boyer; F Durand; Jacques Bernuau; Patrick Marcellin; Claude Degott; Dominique Valla; Dominique Pessayre
Hepatitis after intravenous buprenorphine misuse in heroin addicts.
Journal of hepatology 2001;34(2):346-50.
2001: A Gervais; Nathalie Boyer; P Marcellin
Tolerability of treatments for viral hepatitis.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(5):375-84.
2000: F Habersetzer; Nathalie Boyer; Patrick Marcellin; François Bailly; Si Nafa Si Ahmed; J Alam; Jean-Pierre Benhamou; Christian Trépo
A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C.
Liver 2000;20(6):437-41.
2000: Vincent Di Martino; Thierry Thevenot; Nathalie Boyer; Françoise Degos; Patrick Marcellin
Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients.
Hepatology (Baltimore, Md.) 2000;31(4):1030-1.
2000: Michèle Martinot-Peignoux; Nathalie Boyer; Veronique Le Breton; Gaelle Le Guludec; Corinne Castelnau; Raoudha Akremi; Patrick Marcellin
A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2000;31(3):726-9.
2000: Tarik Asselah; Michèle Martinot; Nathalie Boyer; Patrick Marcellin
[Genetic variability of the hepatitis C virus: clinical implications].
Gastroentérologie clinique et biologique 2000;24(2):175-84.
2000: A Gervais; Y Bacq; Jacques Bernuau; Michèle Martinot; A Auperin; Nathalie Boyer; A Kilani; S Erlinger; Dominique Valla; Patrick Marcellin
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C.
Journal of hepatology 2000;32(2):293-9.
2000: Nathalie Boyer; Patrick Marcellin
Pathogenesis, diagnosis and management of hepatitis C.
Journal of hepatology 2000;32(1 Suppl):98-112.
1999: Patrick Marcellin; Michèle Martinot; Nathalie Boyer; S Lévy
Treatment of hepatitis C patients with normal aminotransferases levels.
Clinics in liver disease 1999;3(4):843-53.
1999: Manuela G Neuman; Jean-Pierre Benhamou; Michèle Martinot; Nathalie Boyer; Neil H Shear; Izabella M Malkiewicz; Gady G Katz; A Suneja; S Singh; Patrick Marcellin
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
Clinical biochemistry 1999;32(7):537-45.
1998: Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; Corinne Castelnau; Nathalie Giuily; V Duchatelle; A Aupérin; Claude Degott; Jean-Pierre Benhamou; S Erlinger; Patrick Marcellin
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
Journal of hepatology 1998;29(2):214-23.
1998: V Duchatelle; Patrick Marcellin; E Giostra; L Bregeaud; M Pouteau; Nathalie Boyer; A Auperin; S Guerret; S Erlinger; D Henin; Claude Degott
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method.
Journal of hepatology 1998;29(1):20-8.
1998: W C Chow; Nathalie Boyer; M Pouteau; Corinne Castelnau; Michèle Martinot-Peignoux; V Martins-Amado; Françoise Degos; C Maghinici; M Sinegre; Jean-Pierre Benhamou; Claude Degott; S Erlinger; Patrick Marcellin
Re-treatment with interferon alfa of patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 1998;27(4):1144-8.
1997: Patrick Marcellin; Nathalie Boyer; A Gervais; Michèle Martinot; M Pouteau; Corinne Castelnau; A Kilani; J Areias; A Auperin; Jean-Pierre Benhamou; Claude Degott; S Erlinger
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
Annals of internal medicine 1997;127(10):875-81.
1997: MA Loriot; Patrick Marcellin; F Walker; Nathalie Boyer; Claude Degott; I Randrianatoavina; Jean-Pierre Benhamou; S Erlinger
Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg.
Journal of hepatology 1997;27(2):251-8.
1997: Michèle Martinot; Patrick Marcellin; Nathalie Boyer; Jill Detmer; M Pouteau; Corinne Castelnau; Claude Degott; A Aupérin; M Collins; Janice A Kolberg; J Wilber; Jean-Pierre Benhamou; S Erlinger
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.
Annals of internal medicine 1997;126(11):874-81.
1995: Patrick Marcellin; M Pouteau; Michèle Martinot; Nathalie Boyer; Corinne Castelnau; Jean-Pierre Benhamou; S Erlinger
[Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives].
Gastroentérologie clinique et biologique 1995;19(12):991-1000.
1995: Michèle Martinot-Peignoux; Patrick Marcellin; M Pouteau; Corinne Castelnau; Nathalie Boyer; M Poliquin; Claude Degott; I Descombes; V Le Breton; V Milotova
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1050-6.
1995: Patrick Marcellin; M Pouteau; Michèle Martinot-Peignoux; Françoise Degos; V Duchatelle; Nathalie Boyer; C Lemonnier; Claude Degott; S Erlinger; Jean-Pierre Benhamou
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Gastroenterology 1995;109(1):156-65.
1995: N Talbodec; M A Loriot; Michele Gigou; V Guigonis; Nathalie Boyer; A Bezeaud; S Erlinger; Jean-Pierre Benhamou; Patrick Marcellin
Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
Liver 1995;15(2):93-8.
1995: M A Loriot; Patrick Marcellin; N Talbodec; V Guigonis; Michele Gigou; Nathalie Boyer; A Bezeaud; S Erlinger; Jean-Pierre Benhamou
Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 1995;21(3):627-31.
1995: Patrick Marcellin; M Pouteau; M A Loriot; Nathalie Boyer; Françoise Degos; P Calès; L Bettan; Y Bacq; H Coppére; jean didier grange
Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication.
Gut 1995;36(3):422-6.
1994: Patrick Marcellin; Nathalie Boyer; Claude Degott; Michèle Martinot-Peignoux; V Duchatelle; E Giostra; J Areias; S Erlinger; Jean-Pierre Benhamou
Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon.
Liver 1994;14(6):302-7.
1994: Patrick Marcellin; Nathalie Boyer; M Pouteau; Jean-Pierre Benhamou; S Erlinger
Retreatment with interferon-alpha of chronic hepatitis C virus infection.
Lancet 1994;344(8923):690-1.
1993: Patrick Marcellin; M Pouteau; Nathalie Boyer; Corinne Castelnau; S Erlinger; Jean-Pierre Benhamou
Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C.
The Journal of infectious diseases 1993;167(3):780-1.
1993: Patrick Marcellin; Vincent Descamps; Michèle Martinot-Peignoux; D Larzul; L Xu; Nathalie Boyer; B N Pham; Béatrice Crickx; L Guillevin; S Belaich
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.
Gastroenterology 1993;104(1):272-7.
1993: Patrick Marcellin; Nathalie Boyer; J F Colin; Michèle Martinot-Peignoux; V Lefort; sophie matheron; S Erlinger; Jean-Pierre Benhamou
Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
Gut 1993;34(2 Suppl):S106.
1992: Nathalie Boyer; Patrick Marcellin; Claude Degott; Françoise Degos; A G Saimot; S Erlinger; Jean-Pierre Benhamou
Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux.
The Journal of infectious diseases 1992;165(4):723-6.
1992: M A Loriot; Patrick Marcellin; E Bismuth; Michèle Martinot-Peignoux; Nathalie Boyer; Claude Degott; S Erlinger; Jean-Pierre Benhamou
Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.
Hepatology (Baltimore, Md.) 1992;15(1):32-6.
1991: Patrick Marcellin; J F Colin; Nathalie Boyer; J Bernuau; Claude Degott; C Hirschauer; Jean-Pierre Benhamou
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon.
Lancet 1991;338(8770):828.
1991: Patrick Marcellin; Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; P Aumont; S Erlinger; Jean-Pierre Benhamou
Second generation (RIBA) test in diagnosis of chronic hepatitis C.
Lancet 1991;337(8740):551-2.
1991: Patrick Marcellin; Nathalie Boyer; E Giostra; Claude Degott; A M Courouce; Françoise Degos; H Coppere; P Cales; P Couzigou; Jean-Pierre Benhamou
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France.
Hepatology (Baltimore, Md.) 1991;13(3):393-7.
1990: Patrick Marcellin; E Giostra; Nathalie Boyer; M A Loriot; Michèle Martinot-Peignoux; Jean-Pierre Benhamou
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?
Journal of hepatology 1990;11(1):77-9.
1990: Patrick Marcellin; M A Loriot; Nathalie Boyer; Michèle Martinot-Peignoux; Claude Degott; Françoise Degos; M Brandely; B Lenfant; Jean-Pierre Benhamou
Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects.
Hepatology (Baltimore, Md.) 1990;12(1):155-8.
1990: Patrick Marcellin; Michèle Martinot-Peignoux; M A Loriot; E Giostra; Nathalie Boyer; Valérie Thiers; Jean-Pierre Benhamou
Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy.
Annals of internal medicine 1990;112(3):227-8.
1989: P Marcellin; G Pialoux; P M Girard; Nathalie Boyer; Michèle Martinot-Peignoux; M A Loriot; M C Dazza; Jean-Pierre Benhamou
Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection.
The New England journal of medicine 1989;321(25):1758.